Concepedia
Statistics
Publications
46
Citations
2.4K
H-Index
32
Active since
1997
Affiliations
AstraZeneca (United Kingdom)(Current)
AnaBios (United States)
Inserm
University of Oxford
AstraZeneca (Singapore)
Najah Abi‐Gerges is an author at AstraZeneca (United Kingdom) specializing in medicine, electrophysiology, and pharmacology.
Publications per year
1997–2024
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks™ HT
Matt Bridgland-Taylor, Alee Hargreaves, Alison Easter et al. · Journal of Pharmacological and Toxicological Methods · 2006 · 150 citations
Engineering, Bioengineering, Biomedical Engineering +9
Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks™
Alexander R. Harmer, Najah Abi‐Gerges, Alison Easter et al. · Journal of Pharmacological and Toxicological Methods · 2007 · 120 citations
Engineering, Bioengineering, Pharmacology +10
An Impedance-Based Cellular Assay Using Human iPSC-Derived Cardiomyocytes to Quantify Modulators of Cardiac Contractility
Clay W. Scott, Xiaoyu Zhang, Najah Abi‐Gerges et al. · Toxicological Sciences · 2014 · 103 citations · Full text
Medicine, Cardiology, Pharmacology +17
Assessment of Cardiomyocyte Contraction in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Amy Pointon, Alexander R. Harmer, Ian L. Dale et al. · Toxicological Sciences · 2014 · 102 citations · Full text
Medicine, Cardiology, Pharmacology +13
Prediction of Thorough QT study results using action potential simulations based on ion channel screens
Gary R. Mirams, Mark Davies, Stephen Brough et al. · Journal of Pharmacological and Toxicological Methods · 2014 · 96 citations · Full text
1–5 of 46